RA Capital Management
RA Capital Management reported 92 stocks worth $10B in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are ASND (23.5%), PBLS (9.4%) and PCVX (6.5%). Compared with Q2 2026, the fund opened new positions in FRNM, AMLX and WVE, added to PBLS, TSHA and ARTV, trimmed SEPN, CLYM and ABVX and sold out of BCRX, WVE and NTLA.
Latest filing: what RA Capital Management did in Q3 2026
vs Q2 2026Dollar changes use the share change at the quarter end price. New and sold out show the whole position.
Portfolio at a glance
share of reported value · Q3 2026Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 | ![]() ASND Ascendis Pharma A/s | $2.3B | 23.5% | 10.3M | No change | 2 of 8 | |
| 2 | ![]() PBLS Parabilis Medicines Inc Com | $942M | 9.4% | 29.2M | +245K (+1%) | 2 of 8 | |
| 3 | ![]() PCVX Vaxcyte Inc | $653M | 6.5% | 11.5M | No change | 8 of 8 | |
| 4 | ![]() RYTM Rhythm Pharmaceuticals Inc | $635M | 6.4% | 6.7M | No change | 8 of 8 | |
| 5 | ![]() EWTX Edgewise Therapeutics Inc | $341M | 3.4% | 8.4M | No change | 8 of 8 | |
| 6 | ![]() TYRA Tyra Biosciences Inc | $267M | 2.7% | 12.2M | No change | 8 of 8 | |
| 7 | ![]() FRNM Freenome Inc | $242M | 2.4% | 15.4M | New position | 1 of 8 | |
| 8 | ![]() COAG Hemab Therapeutics Hldgs Inc | $241M | 2.4% | 7.8M | No change | 2 of 8 | |
| 9 | ![]() NAMS Newamsterdam Pharma Company | $232M | 2.3% | 9.6M | No change | 8 of 8 | |
| 10 | ![]() SEPN Septerna Inc | $215M | 2.2% | 5.5M | −1.5M (−21%) | 8 of 8 |
Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q2 2026, gone in Q3 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
![]() BCRX Biocryst Pharmaceuticals Inc | $158M | 15.8M |
![]() WVE Wave Life Sciences Ltd | $157M | 27M |
NUVALENT INC | $154M | 1.2M |
![]() NTLA Intellia Therapeutics Inc | $76.6M | 4.5M |
![]() DFTX Definium Therapeutics Inc | $70.6M | 1.5M |
🔒 Free account: see all 13.
Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q3 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Nov 16, 2026 | 13F-HR | Q3 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →RA Capital Management 13F FAQ
What does RA Capital Management own?
RA Capital Management reported 92 stocks worth $10B in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are ASND (23.5%), PBLS (9.4%) and PCVX (6.5%). The table above lists every position in the filing (the top 10 without an account).
What did RA Capital Management buy and sell in Q3 2026?
Compared with Q2 2026: 21 new positions, 6 added to, 13 trimmed and 13 sold out. New positions include FRNM, AMLX and WVE. It sold all of BCRX, WVE and NTLA.
When will RA Capital Management file its next 13F?
Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.
How much is RA Capital Management's portfolio worth?
The Q3 2026 filing reports $10B in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.
























